These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy. Binder P; Attre O; Boutin JP; Cavallo JD; Debord T; Jouan A; Vidal D Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):401-21. PubMed ID: 12818625 [TBL] [Abstract][Full Text] [Related]
23. Weapons of mass destruction: Overview of the CBRNEs (Chemical, Biological, Radiological, Nuclear, and Explosives). Prockop LD J Neurol Sci; 2006 Nov; 249(1):50-4. PubMed ID: 16920155 [TBL] [Abstract][Full Text] [Related]
24. Hospital preparedness for chemical and biological incidents in Hong Kong. Chan JT; Yeung RS; Tang SY Hong Kong Med J; 2002 Dec; 8(6):440-6. PubMed ID: 12459601 [TBL] [Abstract][Full Text] [Related]
26. Work on 'non-lethal' weapons should be limited too. Amir Singh J Nature; 2003 Mar; 422(6928):113. PubMed ID: 12634754 [No Abstract] [Full Text] [Related]
27. US bungled investigation into weapons research in Iraq. Giles J; Brumfiel G Nature; 2005 May; 435(7038):5. PubMed ID: 15874983 [No Abstract] [Full Text] [Related]
28. Medical response to a terrorist attack and weapons of mass destruction. Caldicott DG; Edwards NA; Tingey D; Bonnin R Emerg Med (Fremantle); 2002 Sep; 14(3):230-9. PubMed ID: 12487039 [No Abstract] [Full Text] [Related]
29. Deterrence of biological and chemical warfare: a review of policy options. Lebeda FJ Mil Med; 1997 Mar; 162(3):156-61. PubMed ID: 9121658 [TBL] [Abstract][Full Text] [Related]
30. The role of the Department of Defense in domestic weapons of mass destruction consequence management. Cragin CL Mil Med; 2001 Dec; 166(12 Suppl):1-3. PubMed ID: 11778417 [No Abstract] [Full Text] [Related]
31. Technological advancements for the detection of and protection against biological and chemical warfare agents. Eubanks LM; Dickerson TJ; Janda KD Chem Soc Rev; 2007 Mar; 36(3):458-70. PubMed ID: 17325785 [TBL] [Abstract][Full Text] [Related]
32. Biological warfare: bioterrorism. Raghunath D Natl Med J India; 2001; 14(4):194-6. PubMed ID: 11547522 [No Abstract] [Full Text] [Related]
33. Proliferation of biological weapons: challenges and responses. Millett PD Med Confl Surviv; 2004; 20(1):4-18. PubMed ID: 15015544 [TBL] [Abstract][Full Text] [Related]
34. The efforts of WHO and Pugwash to eliminate chemical and biological weapons--a memoir. Kaplan MM Bull World Health Organ; 1999; 77(2):149-55. PubMed ID: 10083714 [TBL] [Abstract][Full Text] [Related]
35. Credible threat: assessing the likelihood of a chemical or biologic attack. Moores LK; Moores LE Respir Care Clin N Am; 2004 Mar; 10(1):1-8. PubMed ID: 15062223 [TBL] [Abstract][Full Text] [Related]
36. Nuclear, biological and chemical warfare. Part III: Medical aspects of chemical warfare. Kasthuri AS; Pradhan AB; Dham SK; Bhalla IP; Paul JS J Assoc Physicians India; 1990 Jun; 38(6):413-4. PubMed ID: 2384457 [No Abstract] [Full Text] [Related]
37. [Update on biological weapons and bioterrorism. Important that health services pay attention to unusual events]. Roffey R; Lantorp K; Tegnell A; Elgh F Lakartidningen; 2001 Dec; 98(50):5746-8, 5751-2. PubMed ID: 11789096 [TBL] [Abstract][Full Text] [Related]
38. Rapid induction of protective tolerance to potential terrorist agents: a systematic review of low- and ultra-low dose research. Szeto AL; Rollwagen F; Jonas WB Homeopathy; 2004 Oct; 93(4):173-8. PubMed ID: 15532694 [TBL] [Abstract][Full Text] [Related]
39. Preparing at the local level for events involving weapons of mass destruction. Hoard ML; Williams JM; Helmkamp JC; Furbee PM; Manley WG; Russell FK Emerg Infect Dis; 2002 Sep; 8(9):1006-7. PubMed ID: 12194786 [No Abstract] [Full Text] [Related]
40. Chemical, biological, and radiological weapons: implications for optometry and public health. Hom GG Optometry; 2003 Feb; 74(2):81-98. PubMed ID: 12585736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]